Form 4 for MDT Medtronic
Accepted 2024-08-06 00:00:00 ET · period of report 2024-08-02 · accession 0001613103-24-000120 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-08-06 | 2024-08-02 | MDT | Wall Brett A. | EVP, Pres Neuroscience | F - Tax | $81.51 | -5,063 | 46.8K | -10% | -$412.7K |
| D | 2024-08-06 | 2024-08-02 | MDT | Wall Brett A. | EVP, Pres Neuroscience | M - OptEx | $0.00 | +5,311 | 49.2K | +12% | $0 |
| D | 2024-08-06 | 2024-08-02 | MDT | Wall Brett A. | EVP, Pres Neuroscience | M - OptEx | $0.00 | -5,311 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2024-08-02 | F | D | 2,701 | $81.51 | 44,106 | D | — | — | (F3) Represents shares withheld for taxes upon the vesting of restricted stock units previously reported on Table I. |
| 2 | Common | Ordinary Shares | 2024-08-02 | M | A | 5,311 | $0.00 | 49,169 | D | — | — | (F1) Represents shares issued upon the settlement of performance-vesting restricted stock units granted on August 2, 2021 and earned dividend equivalents. |
| 3 | Common | Ordinary Shares | 2024-08-02 | F | D | 2,362 | $81.51 | 46,807 | D | — | — | (F2) Represents shares withheld for taxes upon the settlement of performance-vesting restricted stock units that vested on August 2, 2024. |
| 4 | Derivative | Performance Share Units | 2024-08-02 | M | D | 5,311 | $0.00 | 0 | D | — · — to — | 5,311 Performance Share Units | (F4) Each performance share unit represents a contingent right to receive one share of Medtronic common stock. (F5) The performance share units vested on August 2, 2024. |